Literature DB >> 2301820

Identification of interleukin-1 in equine osteoarthritic joint effusions.

E A Morris1, B S McDonald, A C Webb, L J Rosenwasser.   

Abstract

Interleukin-1 (IL-1) is a protein secreted by stimulated cells of the monocyte-macrophage line, which has a number of important biologic activities. Interleukin-1 has been implicated in the induction and augmentation of the pathologic processes involved in arthritis and articular cartilage destruction. Horses develop osteoarthritis with a frequency and degree of severity similar to human beings. To further document the similarity of the osteoarthritic process in people and horses, the synovial fluid from 5 horses with clinical osteoarthritis was tested for IL-1 bioactivity. Interleukin-1 activity was found in all tested synovial fluids. Upon column chromatography, the synovial fluid-derived factor had a molecular weight consistent with that of IL-1 in other mammalian species. Ion exchange chromatography of osteoarthritic synovial fluid revealed the principal peaks of bioactivity to be in the fractions with isoelectric points of 7.2, 5.4, and 4.7, which are characteristic of IL-1. A considerable degree of homology between human and equine IL-1 was demonstrated by the cross hybridization of human IL-1 beta cDNA probe with RNA derived from IL-1-producing equine adherent monocytes. These results indicate that equine IL-1 is in all of the osteoarthritic equine joints tested and that equine IL-1 has many of the characteristics of IL-1 isolated from other species.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2301820

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

Review 1.  Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

Authors:  B Kirkham
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

2.  Recombinant equine interleukin-1beta induces putative mediators of articular cartilage degradation in equine chondrocytes.

Authors:  J T Tung; J I Fenton; C Arnold; L Alexander; V Yuzbasiyan-Gurkan; P J Venta; T L Peters; M W Orth; D W Richardson; J P Caron
Journal:  Can J Vet Res       Date:  2002-01       Impact factor: 1.310

3.  Autologous processed plasma: cytokine profile and effects upon injection into healthy equine joints.

Authors:  Juliana J Moreira; Ana Paula L Moraes; Patrícia M Brossi; Thaís S L Machado; Yara M Michelacci; Cristina O Massoco; Raquel Y A Baccarin
Journal:  J Vet Sci       Date:  2014-09-30       Impact factor: 1.672

4.  Effects of medical ozone upon healthy equine joints: Clinical and laboratorial aspects.

Authors:  Cynthia do Prado Vendruscolo; Juliana Junqueira Moreira; Sarah Raphaela Torquato Seidel; Joice Fülber; Henrique Macedo Neuenschwander; Giancarlo Bonagura; Fernanda Rodrigues Agreste; Raquel Yvonne Arantes Baccarin
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

5.  Macrophage Activation in the Synovium of Healthy and Osteoarthritic Equine Joints.

Authors:  Bruno C Menarim; Kiersten H Gillis; Andrea Oliver; Ying Ngo; Stephen R Werre; Sarah H Barrett; Dwayne H Rodgerson; Linda A Dahlgren
Journal:  Front Vet Sci       Date:  2020-11-26

6.  Cathepsin g Degrades Both Glycosylated and Unglycosylated Regions of Lubricin, a Synovial Mucin.

Authors:  Shan Huang; Kristina A Thomsson; Chunsheng Jin; Sally Alweddi; André Struglics; Ola Rolfson; Lena I Björkman; Sebastian Kalamajski; Tannin A Schmidt; Gregory D Jay; Roman Krawetz; Niclas G Karlsson; Thomas Eisler
Journal:  Sci Rep       Date:  2020-03-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.